Responsive image
博碩士論文 etd-0802105-153541 詳細資訊
Title page for etd-0802105-153541
Economic Impact of Nosocomial Infection
Year, semester
Number of pages
Advisory Committee
Date of Exam
Date of Submission
nosocomial infections management, nosocomial infections control, nosocomial infections economics, Nosocomial infections
本論文已被瀏覽 5719 次,被下載 0
The thesis/dissertation has been browsed 5719 times, has been downloaded 0 times.
Nosocomial infections present an important health problem with morbidity, and high mortality, prolongation hospital days, and increased direct costs of patient care. This article was conducted in a general hospital in order to determine the cost of nosocomial infections and increased length of hospitalization of it. The conclusion was that the high economic expense which nosocomial infection represents justifies measures to control this entity. Nosocomial infections are a major part of the problem of reemerging pathogens causing infectious diseases, affecting 5% of hospitalized patients. Provided an enhanced, integrated infection control program, it could be assessed that the medical and economic effects on the overall nosocomial infection will lower of actual health care costs by $28000NTD each case of the intervention.
目次 Table of Contents
. Preventing Nosocomial Infections
. Prevention not Rewarded
. Antibiotics Overused
. Extra Cost
. Extra Length of Stay
. Extra Mortality
. Infection Control Programme
. Quality Costs
. Financial Costs
. The Infection Control Workforce
. Infection Control Surveillance Project
. The Case for Surveillance
. Targeted Surveillance
. Aggregated Data and Inter-Hospital
參考文獻 References
1. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: Morbidity, mortality, cost and prevention. Infect Control Hosp Epidemiol 1996;17:552-7.
2. Platt R, Goldmann DA, Hopkins CC. Epidemiology of nosocomial infections. In: Gorbach SL, Bartlett JG, Blacklow NR, editors. Infectious Diseases 2nd edn. Philadelphia: WB Saunders Comp; 1998. pp.108-22.
3. Plowman R, Graves N, Griffin MAS, Roberts JA, Swan AV, Cookson B, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialities of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198-209.
4. Nettlemann MD. Cost-effectiveness and cost-benefit analysis in infection control In: Wenzel RP, editor. Prevention and control of nosocomial infections. 3rd edn. Baltimore: Williams & Wilkins; 1997. pp. 19-32.
5. Haley RW. Cost-benefit analysis of Infection control programs. In: Bennett JV, Brachman PS editors. Hospital Infections 4th edn. Philadelphia: Lippincott-Raven Publishers;1998: 249-67.
6. Mundy LM, Fraser V. Determining the cost-effectiveness of hospital epidemiology and infection control programs. In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. 2nd edn. Philadelphia: Lippincott Williams and Wilkins; 1999:1437-43.
7. Wilcox MH, Dave J. The cost of hospital-acquired infection and the value of infection control. J Hosp Infect 2000;45:81-4.
8. Westwood JCN, Legrace S, Mitchell MA. Hospital acquired infection: Present and future impact and need for positive action. Can Med Assoc J 1974;110:769-74.
9. Haley RW, Schaberg Dr. Van Allmen SD, Mc Gowen JE. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections:A comparison of methods. J Infect Dis 1980;14:248-57.
10. Coello R, Glenister H, Foreres J, Bartlett C, Leigh D, Sedgwick J, et al. The cost of infection in surgical patients: a-case control study. J Hosp Infect 1993;25:239-50.
11. Diaz Molina C, Garcia Martin M, Buena Cavanillas A, Lopez Luque A, Delgado Rodriguez M. The estimation of the cost of nosocomial infection in an intensive care unit. Medicina Clinica 1993;100:329-32.
12. Yalcin AN, Hayran M, Unal S. Economic analysis of nosocomial infections in a Turkish University Hospital. J Chemother 1997;9:411-4.
13. Orrett FA, Brooks PJ, Richardson EG. Nosocomial infections in a rural Regional Hospital in a developing country: Infection rates by site, service, cost and infection control practices. Infect Control Hosp Epidemiol 1998;19:136-40.
14. Mahieu LM, Buitenweg N, Beutels P, De Dooy JJ. Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. J Hosp Infect 2001;47:223-9.
15. Leroyer A, Bedu A, Lombrail P, Desplanques L, Diakite B, Bingen E, et al. Prolongation of hospital stay and extra costs due to hospital acquired infection in a neonatal unit. J Hosp Infect 1997;35:37-45.
16. Astagneau P, Fleury L, Leroy S, Lucet JC, Golliot F, Regnier B, et al. Cost of antimicrobial treatment of nosocomial infections based on a French prevalence survey. J Hosp Infect 1999;42:303-12.
17. Yalcin AN, Turgut H, Cetin CB, Tefci F. Cost of antibiotics in nosocomial infections. Turk J Hosp Infect 2002;6:41-5.
18. French GL, Cheng AFB. Measurement of the costs of hospital infection by prevalence surveys. J Hosp Infect 1991;18:S65-72.
19. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: Attributable mortality and length of stay. Am J Infect Control 2003;31:291-5.
20. Dinkel RH, Lebok V. A survey of nosocomial infections and their influence on hospital mortality rates. J Hosp Infect 1994;28:297-304.
21. Plowman R. The socioeconomic burden of hospital acquired infection. Euro Surveill 2000;5:49-50.
22. Kumasaka K, Yanai M. Costs and benefits in hospital infection control. Nippon Rinsho 2002;60:2230-5.
23. Gaynes R, Richards C, Edwards J, Emori TG, Horan T, Alonso-Echanove J, et al. Feeding back surveillance data to prevent Hospital-acquired infections. Emerg Infect Dis 2001;7:295-8.
24. Horan T, Saint S, Chenoweth C, Fendrick AM. The role of economic evaluation in infection control. Am J Infect Control 2001;29:338-44.
25. Daschner F. Cost-effectiveness in hospital infection control-lessons for the 1990s. J Hosp Infect 1989;13:325-36.
26. Starling CE, Couto BR, Pinheiro SM. Applying the Centers for Disease Control and Prevention and National Nosocomial Surveillance system methods in Brazilian hospitals. Am J Infect Control 1997;25:303-11.
27. Haley RW, White JW, Culver DH, Hughes JM. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system: an empirical determination from a nationally representative sample. JAMA 1987;257:1611-4.
28. Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003;54: 258-66.
29. Graves N, Plowman R, Roberts JA.The epic project: developing national evidence-based guidelines for preventing healthcare associated infections.J Hosp Infect 2001;48:320-1.
30. Graves N, Nicholls TM, Morris AJ. Modeling the costs of hospital-acquired infections in New Zealand. Infect Control Hosp Epidemiol 2003;24:214-23.
31. Roberts RR, Scott RD 2nd, Cordell R, Solomon SL, Steele L, Kampe LM, et al. The use of economic modeling to determine the hospital costs associated with nosocomial infections. Clin Infect Dis 2003;36:1424-32
電子全文 Fulltext
論文使用權限 Thesis access permission:校內校外均不公開 not available
開放時間 Available:
校內 Campus:永不公開 not available
校外 Off-campus:永不公開 not available

您的 IP(校外) 位址是
論文開放下載的時間是 校外不公開

Your IP address is
This thesis will be available to you on Indicate off-campus access is not available.

紙本論文 Printed copies
開放時間 available 已公開 available

QR Code